Amsterdam, Netherlands

Carsten Linnemann

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Carsten Linnemann: Innovating Cancer Treatment through T Cell Research

Introduction

Carsten Linnemann is a notable inventor based in Amsterdam, Netherlands, who has made significant contributions to the field of cancer research. With a focus on T cell receptors and peptides, Linnemann has been pivotal in developing methods that enhance cancer treatment. He holds two patents, both aimed at improving the efficacy of T cell therapies.

Latest Patents

Linnemann's latest patents address critical advancements in the treatment of cancer. The first patent describes a method for providing a neopeptide-specific T cell, wherein the T cell forms a stable complex with a neopeptide-MHC monomer, exhibiting a half-life (T½) of at least 50 seconds. This innovative approach is designed to improve the effectiveness of T cell therapies. The second patent outlines improved screening methods for testing T cell recognition of T cell epitopes. These methods are crucial for refining how T cells interact with cancer cells, thereby enhancing therapeutic approaches.

Career Highlights

Throughout his career, Carsten Linnemann has been associated with reputable organizations including Aimm Therapeutics B.V. and Stichting Het Nederlands Kanker Instituut – Antoni van Leeuwenhoek Ziekenhuis. His work in these institutions has contributed significantly to advancing T cell therapies and understanding the immune response to cancer.

Collaborations

Linnemann has collaborated with several esteemed professionals in the field, including his coworkers Laura Bies and Marit Martha van Buuren. These collaborations have been instrumental in evolving research methodologies and fostering innovation in cancer treatment paradigms.

Conclusion

Carsten Linnemann's work exemplifies the drive for innovation in the medical field, particularly in cancer treatment through T cell research. His patents not only reflect his dedication as an inventor but also signify a critical advancement in therapeutic strategies, potentially improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…